Parkinson's Disease - McKnight's Long Term Care News

Parkinson’s Disease

Clinical briefs for Monday, June 14

3 FDA advisory panel members resign in wake of controversial approval of new Alzheimer’s drug … U.S. suspends COVID J&J vaccine shipments as backlog builds; extends expiration dates … VoiceFriend adds new discharged patient module for post-acute care … Computerized tests show how poorly fitting N95 masks increase risk of infection … FDA recalls unapproved COVID test that used falsified data … Parkinson’s drug candidates to be targeted to genetic groups in new Abbie biopharma collaboration

Clinical briefs for Wednesday, May 26

The true scope of COVID? 20% of hospitalized patients not discharged to home … HHS re-ups provider reimbursement for testing uninsured patients for COVID … Feds, nonprofits surpass big pharma in Alzheimer’s drug development … Don’t be surprised to see the return of COVID this fall, market watcher says … Researchers develop levodopa nasal spray gel for Parkinson’s … Following physical activity guidelines reduces afib and stroke risk in new study

Clinical briefs for Tuesday, April 27

Frailty and cognitive impairment not reasons to withhold anticoagulation in atrial fibrillation, docs say … Parkinson’s patients’ treatment goals reflect disease progression … Study looks at how nurses view touch as a form of care … Tendency toward neuroticism linked to Parkinson’s risk … CDC study tracks COVID symptoms to six months beyond diagnosis

Clinical briefs for Monday, April 26

Long-term care COVID cases and deaths at all-time low, report finds… Kinless elders require expanded LTC services at end-of-life, researchers contend … Amgen tests souped-up remote heart monitoring platform to tackle chronic heart failure … People with Parkinson’s disease show preference for high-motion artworks … FDA OKs marketing of device that promotes post-stroke muscle re-training

Next post in Clinical Daily News